Response to letter to the Editor| Volume 425, 117469, June 15, 2021

Reply to: Neurometabolic causes of dystonia: Sepiapterin reductase-deficient dopamine- and serotonin-responsive dystonia-plus syndrome

  • Chun Seng Phua
    Corresponding author at: Department of Neurosciences, Alfred Hospital, 55 Commercial Road, Melbourne, VIC 3004, Australia.
    Department of Neurosciences, Alfred Hospital, Melbourne, VIC, Australia

    Monash School of Medicine, Monash University, Melbourne, VIC, Australia
    Search for articles by this author
  • Kishore Raj Kumar
    Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia

    Molecular Medicine Laboratory, Concord Repatriation General Hospital, Sydney, NSW, Australia

    Neurology Department, Concord Repatriation General Hospital, Sydney, NSW, Australia

    Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia
    Search for articles by this author
  • Stanley Levy
    Department of Neurology, Campbelltown Hospital, NSW, Australia

    University of Western Sydney, School of Medicine, NSW, Australia
    Search for articles by this author
Published:April 20, 2021DOI:
      Dear editor,


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Phua C.S.
        • Kumar K.R.
        • Levy S.
        Clinical characteristics and diagnostic clues to Neurometabolic causes of dystonia [Internet].
        J. Neurol. Sci.. Els. B.V. 2020; 419
        • Furukawa Y.
        • Kish S.
        Ardinger H.H. Adam M.P. Pagon R.A. Tyrosine Hydroxylase Deficiency. [Updated 2017 May 11]. GeneReviews® [Internet]. University of Washington, Seattle, Seattle (WA)2008 Feb 8 (Available from:)
        • Willemsen M.A.
        • Verbeek M.M.
        • Kamsteeg E.J.
        • De Rijk-Van Andel J.F.
        • Aeby A.
        • Blau N.
        • et al.
        Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis.
        Brain. 2010 Jun; 133: 1810-1822
        • Shalash A.S.
        • Rösler T.W.
        • Müller S.H.
        • Salama M.
        • Deuschl G.
        • Müller U.
        • et al.
        c.207C>G mutation in sepiapterin reductase causes autosomal dominant dopa-responsive dystonia.
        Neurol. Genet. 2017 Nov 1; 3: e197
        • Dill P.
        • Wagner M.
        • Somerville A.
        • Thöny B.
        • Blau N.
        • Weber P.
        Child neurology: paroxysmal stiffening, upward gaze, and hypotonia, Hallmarks of sepiapterin reductase deficiency.
        Neurology. 2012 Jan; 31: 78(5)
        • Antelmi E.
        • Stamelou M.
        • Liguori R.
        • Bhatia K.P.
        Nonmotor Symptoms in Dopa-Responsive Dystonia [Internet]. Vol. 2, Movement Disorders Clinical Practice.
        Wiley-Blackwell, 2015: 347-356
        • Marras C.
        • Lang A.
        • van de Warrenburg B.P.
        • Sue C.M.
        • Tabrizi S.J.
        • Bertram L.
        • et al.
        Nomenclature of genetic movement disorders: Recommendations of the international Parkinson and movement disorder society task force [Internet].
        in: Movement Disorders. vol. 31. John Wiley and Sons Inc, 2016: 436-457
        • Timmers E.R.
        • Kuiper A.
        • Smit M.
        • Bartels A.L.
        • Kamphuis D.J.
        • Wolf N.I.
        • et al.
        Non-motor symptoms and quality of life in dopa-responsive dystonia patients.
        Parkinsonism Relat. Disord. 2017 Dec 1; 45: 57-62
        • Wijemanne S.
        • Jankovic J.
        Dopa-responsive dystonia - Clinical and genetic heterogeneity [Internet].
        in: Nature Reviews Neurology. vol. 11. Nature Publishing Group, 2015: 414-424
        • Furukawa Y.
        Adam M.P. Ardinger H.H. Pagon R.A. Wallace S.E. LJH Bean Stephens K. GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia. 2019 (editors. Seattle (WA))